Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,325 questions in 34 reviews · Oral medicine and oral cancer
current versionsNo studies 164 · 12.4%Ungraded 841 · 63.5%Very low 209 · 15.8%Low 72 · 5.4%Moderate 38 · 2.9%High 1 · 0.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Antifungal drugs partially absorbed from GI tract (miconazole, clotrimazole) vs Placebo or no treatment Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.16 [0.06, 0.46] | 4 studies · 292 participants | Ungraded |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Amount of analgesia · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | No trial reported this planned secondary outcome for any comparison in this review | NR | No studies |
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract Systemic fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.59 [0.33, 1.06] | 8 studies · 2103 participants | Ungraded |
Itraconazole vs Fluconazole Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.14 [0.01, 2.73] | 1 study · 202 participants | Ungraded |
Itraconazole vs Fluconazole Good compliance · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.95 [0.85, 1.05] | 1 study · 202 participants | Ungraded |
Antifungal drugs partially absorbed from GI tract (miconazole, clotrimazole) vs Placebo or no treatment Empirical antifungal treatment · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 3.38 [0.15, 77.12] | 1 study · 32 participants | Ungraded |
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 1.25 [0.38, 4.13] | 3 studies · 981 participants | Ungraded |
Nystatin vs Chlorhexidine plus nystatin Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 1.82 [0.73, 4.54] | 1 study · 50 participants | Ungraded |
Antifungal drugs not absorbed from GI tract vs Placebo or no treatment Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.16 [0.01, 2.95] | 1 study · 51 participants | Ungraded |
Chlorhexidine vs Nystatin Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.89 [0.36, 2.21] | 1 study · 34 participants | Ungraded |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Relief of pain · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | No trial reported this planned secondary outcome for any comparison in this review | NR | No studies |
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract Good compliance · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 1.05 [1.03, 1.08] | 1 study · 820 participants | Ungraded |
Nystatin vs Placebo or no treatment Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.92 [0.78, 1.08] | 3 studies · 153 participants | Ungraded |
Nystatin vs Natamycin Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 1.07 [0.83, 1.37] | 1 study · 28 participants | Ungraded |
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.4 [0.21, 0.76] | 8 studies · 2103 participants | Ungraded |
Antifungal drugs not absorbed from GI tract vs Placebo or no treatment Systemic fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.1 [0.01, 1.75] | 2 studies · 71 participants | Ungraded |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Toxicity (adverse events probably due to drug) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 1.18 [0.84, 1.67] | 3 studies · 871 participants | Ungraded |
Ketoconazole vs Itraconazole Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | 1 study (Caselli 1990); no evidence of a difference; not estimable/not pooled | 1 study | Ungraded |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.47 [0.29, 0.78] | 7 studies · 1153 participants | Ungraded |
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract Toxicity (adverse events probably due to drug) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane | RR 0.88 [0.33, 2.3] | 6 studies · 2018 participants | Ungraded |
Tongue scraping (mechanical tongue cleaning) vs Placebo or no intervention (nothing) Outcome NR · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned) Tongue scraping for treating halitosis (2006) · Cochrane | No eligible randomized controlled trials comparing tongue scraping with placebo or no intervention were identified. | 0 studies | No studies |
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue) Volatile sulfur compound (VSC) levels measured by portable sulfide monitor · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Immediately to 35 min post-intervention (Seemann 2001); 1 week (Pedrazzi 2004) Tongue scraping for treating halitosis (2006) · Cochrane | No summary of findings table or GRADE assessment (pre-GRADE review); narrative synthesis, data not pooled. Seemann 2001: peak VSC reduction 42% with the tongue cleaner, 40% with the tongue scraper and 33% with the… | 2 studies · 40 participants | Ungraded |
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue) Adverse effects (tongue trauma, nausea) and acceptability · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · 1 week (Pedrazzi 2004) Tongue scraping for treating halitosis (2006) · Cochrane | Pedrazzi 2004: six of ten (60%) participants complained of nausea and one participant of tongue trauma, only with the toothbrush; all participants were receptive to the tongue scraper. Seemann 2001: no adverse effects… | 2 studies | Ungraded |
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue) Self-expressed (perceived) or organoleptic (human nose) assessment of halitosis · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned) Tongue scraping for treating halitosis (2006) · Cochrane | Neither of the two included trials provided any self expressed (perceived) or organoleptic (human nose) assessments of halitosis (the review's primary outcomes); no data. | 0 studies | No studies |
Tongue scraping (mechanical tongue cleaning) vs Mouthwash or other chemical intervention Outcome NR · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned) Tongue scraping for treating halitosis (2006) · Cochrane | No randomized controlled trials comparing mechanical tongue cleaning with mouthwashes were identified; the review notes "the somewhat unexpected lack of randomized controlled trials comparing the effectiveness of… | 0 studies | No studies |